These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9036880)

  • 1. Cell proliferation in 3,800 node-negative breast cancers: consistency over time of biological and clinical information provided by 3H-thymidine labelling index.
    Silvestrini R; Daidone MG; Luisi A; Mastore M; Leutner M; Salvadori B
    Int J Cancer; 1997 Feb; 74(1):122-7. PubMed ID: 9036880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro thymidine labelling index in primary operable breast cancer.
    Holt S; Croton R; Leinster SJ; McDicken I; Nicholson RI; Cooke TG; George WD
    Eur J Surg Oncol; 1986 Mar; 12(1):53-7. PubMed ID: 3956755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
    Silvestrini R; Benini E; Daidone MG; Veneroni S; Boracchi P; Cappelletti V; Di Fronzo G; Veronesi U
    J Natl Cancer Inst; 1993 Jun; 85(12):965-70. PubMed ID: 8496982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferative index of breast carcinoma by thymidine labeling: prognostic power independent of stage, estrogen and progesterone receptors.
    Meyer JS; Province M
    Breast Cancer Res Treat; 1988 Oct; 12(2):191-204. PubMed ID: 3242648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of biologic markers in node-negative breast cancer patients: a prospective study.
    Volpi A; De Paola F; Nanni O; Granato AM; Bajorko P; Becciolini A; Scarpi E; Riccobon A; Balzi M; Amadori D
    Breast Cancer Res Treat; 2000 Oct; 63(3):181-92. PubMed ID: 11110052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. nm23 expression in human breast cancer: correlation with cell proliferation (S-phase) as observed with a double-labeling immunocytochemical-autoradiographic technique.
    Simone G; Mangia A; Petroni S; Trotti I; Paradiso A; Marzullo F; De Lena M; Leone A
    Int J Oncol; 1998 May; 12(5):1055-9. PubMed ID: 9538128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer.
    Silvestrini R; Luisi A; Zambetti M; Cipriani S; Valagussa P; Bonadonna G; Daidone MG
    Int J Cancer; 2000 Aug; 87(3):405-11. PubMed ID: 10897047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of p53 accumulation as a predictor of distant metastasis at 10 years of follow-up in 1400 node-negative breast cancers.
    Silvestrini R; Daidone MG; Benini E; Faranda A; Tomasic G; Boracchi P; Salvadori B; Veronesi U
    Clin Cancer Res; 1996 Dec; 2(12):2007-13. PubMed ID: 9816160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidine labeling index: prognostic role in breast cancer.
    Bilir A; Ozmen V; Kecer M; Eralp Y; Cabioglu N; Ahishali B; Camlica H; Aydiner A
    Am J Clin Oncol; 2004 Aug; 27(4):400-6. PubMed ID: 15289735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymidine labeling index and Ki-67 growth fraction in breast cancer: comparison and correlation with prognosis.
    Rudas M; Gnant MF; Mittlböck M; Neumayer R; Kummer A; Jakesz R; Reiner G; Reiner A
    Breast Cancer Res Treat; 1994; 32(2):165-75. PubMed ID: 7865846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and predictive value of thymidine labelling index in breast cancer.
    Amadori D; Silvestrini R
    Breast Cancer Res Treat; 1998; 51(3):267-81. PubMed ID: 10068084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological characterisation of primary and metachronous lesions in breast cancer patients.
    Silvestrini R; Valentinis B; Daidone MG; Di Fronzo G; Coradini D; Salvadori B
    Eur J Cancer; 1992; 28A(12):2006-10. PubMed ID: 1419299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyl-p-hydroxyphenyllactate-esterase activity in breast cancer: a potentially new prognostic factor in short-term follow-up.
    Carbone A; Serra FG; Ferrandina G; Scambia G; Terribile D; Bellantone R; Piantelli M; Ranelletti FO
    Cancer Res; 1997 Dec; 57(23):5406-9. PubMed ID: 9393767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of proliferative activity and ploidy in node-negative breast cancers.
    Silvestrini R; Daidone MG; Del Bino G; Mastore M; Luisi A; Di Fronzo G; Boracchi P
    Ann Oncol; 1993 Mar; 4(3):213-9. PubMed ID: 8471553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laminin receptors, collagenase IV and prognosis in node-negative breast cancers.
    Daidone MG; Silvestrini R; D'Errico A; Di Fronzo G; Benini E; Mancini AM; Garbisa S; Liotta LA; Grigioni WF
    Int J Cancer; 1991 Jun; 48(4):529-32. PubMed ID: 1646175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].
    Fodor J
    Magy Onkol; 2009 Mar; 53(1):7-14. PubMed ID: 19318321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term prognostic significance of thymidine labelling index in primary breast cancer.
    Cooke TG; Stanton PD; Winstanley J; Murray GD; Croton R; Holt S; George WD
    Eur J Cancer; 1992; 28(2-3):424-6. PubMed ID: 1591056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional heterogeneity in breast carcinoma: thymidine labelling index, steroid hormone receptors, DNA ploidy.
    Meyer JS; Wittliff JL
    Int J Cancer; 1991 Jan; 47(2):213-20. PubMed ID: 1988366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of the Tritiated Thymidine Labeling Index in breast cancers.
    Araki K; Kimura M; Sakamoto K; Nishimura R; Akagi M
    Jpn J Surg; 1985 Mar; 15(2):144-9. PubMed ID: 4010096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
    Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
    Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.